Ek. Jang et al., SYNERGISTIC INHIBITORY EFFECTS OF ATRIOPEPTIN-II AND ISOPROTERENOL ONCONTRACTION OF RAT AORTIC SMOOTH-MUSCLE - ROLES OF CGMP AND CAMP, European journal of pharmacology, 250(3), 1993, pp. 477-481
Atriopeptin II and isoproterenol acted synergistically to inhibit the
phenylephrine-induced contraction of aortic smooth muscle from Wistar-
Kyoto (WKY) rats. Thus, a weakly inhibitory concentration of atriopept
in II (10 nM) caused a 5-fold decrease in the IC50 of isoproterenol fr
om 169 nM to 32 nM, whereas a low concentration of isoproterenol (100
nM) increased the maximum inhibition attributable to atriopeptin II fr
om 43% to 74%. Atriopeptin TI(10 nM) increased the cGMP found in aorti
c smooth muscle and approximately doubled the accumulation of cAMP cau
sed by isoproterenol. The results suggest that cGMP, formed by the act
ion of atriopeptin II on receptor guanylyl cyclase (GC-A), may inhibit
aortic cyclic nucleotide phosphodiesterase type III (PDE III) and tha
t an increased accumulation of cAMP then mediates the observed synergi
sm.